Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2023-01-23
2024-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Pathophysiology of dystonia is still not elucidated. Motor cortex hyperexcitability has been demonstrated in various forms of dystonia. Furthermore, rTMS inhibitory applied over motor cortex has been shown to transitory reduce dystonic symptoms in various forms of dystonia.
In the present study, we investigate the effect of a single 1Hz 20-minutes inhibitory rTMS session applied over the motor laryngeal cortex on dyasarthria is the main kinetic dysarthria has been shown to be associated with inhibition of laryngeal motor cortex in Parkinson disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inhibitory rTMS in Dystonic Wilson Patients
NCT01980433
Cortical Silent Period in Laryngeal Dystonia
NCT05580302
Cerebellar Metaplasticity in the Swallowing Motor System
NCT06721533
Effect of Pharyngeal Inhibition by rTMS on Swallowing Function
NCT02170454
Effects of Neuromodulation in Laryngeal Dystonia
NCT05095740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will receive 3 days apart to two rTMS sessions.
rTMS procedures will be performed with a figure of eight coiled. A single 20-minutes 1 Hz biphasic stimulation (1200 pulses) session will be applied over the laryngeal motor cortex. A brain imaging positioning device will be used during all the procedure A second stimulation session will be performed 3 days apart.
Patients will be centrally randomized to receive first either the active stimulation (80% of the resting motor threshold) or the sham stimulation (using a visually identical coil to reproduce the click sound and the scalp sensation of the active coil).
A TMS evaluation of cortical silent period over the left motor cortex will be performed before the first rTMS session.
Before and immediately after each stimulation (active or sham) patient will received an clinical evaluation including Clinical Assessment Battery for Dysarthria intelligibility score, "A" phonation time, diadococinesia , bucco-linguo-facial motricity score and UWDRS.
A standard 20-minutes EEG will be performed before the first rTMS session and immediately after the second rTMS session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental stimulation
Patients receive an inhibitor treatment of rTMS using activ coil (MCF B65 coil) for 30 minutes at 1Hz at 80% of the resting motor threshold (MagPro stimulator; MagVenture A / S, Farum, Denmark) onto the left laryngeal cortex located thanks to a neuronavigation device (Syneika one \[SYN1\], Syneika, Cesson-Sévigné, France).
rTMS
Single 30-minutes session of 1Hz rTMS applied over the left laryngeal motor cortex
Sham stimulation
Patients receive a treatment of rTMS using placebo coil (MCF P B65 coil) for 30 minutes at 1Hz (MagPro stimulator; MagVenture A / S, Farum, Denmark) onto the left laryngeal cortex located thanks to a neuronavigation device (Syneika one \[SYN1\], Syneika, Cesson-Sévigné, France).
Sham stimulation
Single 30-minutes session of sham stimulation applied over the left laryngeal motor cortex
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rTMS
Single 30-minutes session of 1Hz rTMS applied over the left laryngeal motor cortex
Sham stimulation
Single 30-minutes session of sham stimulation applied over the left laryngeal motor cortex
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Wilson disease with dystonic hyperkinetic dysarthria
* Stable pharmacological therapy n the last 6 monts
* Brain MRI in the previous 6 months, without additional brain lesion
* Patients that did not receive botulinium toxin in the previous 4 months
Exclusion Criteria
* Previous mdedical history of epilepsia
* Pregnancy or breastfeeding
* Brain lesion outside basal ganglia on brain MRI
* Patient consider by the investigator not able to sustain an 30 minutes rTMS session without moving
* Vocal chord lesion
* Previous history of laryngeal surgery
* rTMS contra indication
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Physiologie Clinique-Explorations Fonctionnelles, AP-HP, Hôpital Lariboisière
Paris, , France
Service de Neurologie, Hopital Fondation Adolphe de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D20180404
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.